about
Tuberous sclerosis diagnosed by incidental computed tomography findings of multifocal micronodular pneumocyte hyperplasia: a case reportSerum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesEfficacy and safety of sirolimus in lymphangioleiomyomatosis.Lymphangioleiomyomatosis: differential diagnosis and optimal managementA Total Pleural Covering for Lymphangioleiomyomatosis Prevents Pneumothorax RecurrenceTSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.Management of lymphangioleiomyomatosisClinical features, epidemiology, and therapy of lymphangioleiomyomatosisTuberous sclerosis with pulmonary lymphangioleiomyomatosis and renal angiomyolipomas. Computed tomographic findings: a case report.Rapamycin-insensitive up-regulation of MMP2 and other genes in tuberous sclerosis complex 2-deficient lymphangioleiomyomatosis-like cells.Diffuse Cystic Lung Disease. Part I.Diffuse Cystic Lung Disease. Part II.The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.Involvement of lymphatics in lymphangioleiomyomatosisClinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis.Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis.A nationwide survey of lymphangioleiomyomatosis in Korea: recent increase in newly diagnosed patients.Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.Recovery of chylous pulmonary congestion in tuberous sclerosis complex-associated lymphangioleiomyomatosis.Unusual causes of pneumothoraxSerum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trialPhenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosisCT and MR imaging findings of lymphangioleiomyomatosis involving the uterus and pelvic cavity.MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM).Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex.Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosisSustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapyPulmonary arterial involvement leading to alveolar hemorrhage in lymphangioleiomyomatosis.Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis.Pulmonary lymphangioleiomyomatosis associated with retroperitoneal lymphangioleiomyomasLymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell StemnessFavorable response to antigonadal therapy for a benign metastasizing leiomyomaWomen with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis.Coexistence of pulmonary lymphangioleiomyomatosis and pulmonary angiomyolipoma.Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosisAnesthesia for suboccipital craniotomy in a patient with lymphangioleiomyomatosis: a case report.Tuberous sclerosis complex: neurological, renal and pulmonary manifestationsLymphangioleiomyomatosis - a wolf in sheep's clothing.
P2860
Q21202080-FA60079C-6308-426E-9936-7B0A9CFF5769Q24608283-1D997DCD-BB70-4278-BAA4-3D12BDED5595Q24610039-515D47B7-054F-4E4E-86E6-54DCBE5DF48CQ27022412-A9C8996A-58E3-40FE-99A1-C20EE13CD96AQ27321304-41E4A6F7-5778-413E-BAF7-6290D4368C14Q27851543-2B1D0D4E-959A-4DCE-95A8-D0B6890E6554Q28084725-26A621E7-C36C-407F-AE5D-5E967B4E01BAQ28084975-DD602A50-16A6-426A-9028-CBBC1DEA77F9Q33580383-F5BF7ABB-5EC0-4AF6-A3DC-F39F8DFC34D4Q33658836-78965D46-CDA3-4B14-8032-3503744B5130Q33722950-D573207A-092F-47B0-8E46-2EE6855750C0Q33735622-5CC83F96-604B-4A2F-A13E-1593BE999BCDQ33905090-A23E6F52-99D2-4023-895E-A6F9EAE6A317Q33905141-EFC521AA-9DB3-48DB-A0C8-96320EF29CFAQ33905175-F68E5306-0432-4E80-BFB1-48ADA3DB5021Q33963293-5600A598-3E76-4916-8072-038D1F08A475Q34014774-95CB5117-D8C9-4543-A9CE-3ED44274CB9DQ34194187-260E1F93-78C6-43F7-97B6-9B6745289E35Q34365375-02E298BF-E756-4256-8DC8-32E26A8F7BD9Q34375358-DA835B1A-DC2F-42DB-9758-3193A8690FDDQ34380247-696031E0-4705-4160-B309-4EE6FF40E1BFQ34535040-33D54F5B-C4AE-46E0-8D15-E767CD5CB95DQ34642098-A08E6E18-728A-462E-A7A0-63C735FD01CDQ34652936-4C330DDE-176F-4033-B793-389BD932DFF4Q34755802-A0148E06-3E57-4E19-90C4-3DE42DE5EE54Q34840298-81D586B0-E91C-4AC2-88DD-AF134477109CQ35044713-BCB7AD06-B38F-448F-97CB-74A18D5DFAF9Q35049412-10A83F49-BB3A-4481-A259-60DA58EC8763Q35107703-DAF6DB32-004B-4752-81F9-1B3402DC941FQ35142017-753A0E80-0B40-4B7A-B2F8-81B591FD2099Q35531599-5903BB27-479D-4414-A586-5D2B8B5A47CDQ35685902-7C110533-EF5B-4B91-A510-C0FA345836F9Q35689467-22A3884B-34D4-448C-8192-48214F820D37Q35697421-084A2EE2-919D-4046-8E2C-025F38E12A36Q36015287-81FE337A-C781-4898-8960-ED6BBB80EF65Q36104539-FEB7C62E-1B36-4D43-A329-77EBB970D5FDQ36144597-A16767AB-7F91-462A-B7C8-E160F0CE7ABEQ36168481-48A656E0-BAE4-4EA5-8029-3D14559C9119Q36239644-486F31E3-2DEB-4BFA-8F7E-3E3E4F1F3392Q36357766-F7EE312A-833F-42BD-904F-2E66827CEF7D
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Lymphangioleiomyomatosis: a clinical update.
@ast
Lymphangioleiomyomatosis: a clinical update.
@en
Lymphangioleiomyomatosis: a clinical update.
@nl
type
label
Lymphangioleiomyomatosis: a clinical update.
@ast
Lymphangioleiomyomatosis: a clinical update.
@en
Lymphangioleiomyomatosis: a clinical update.
@nl
prefLabel
Lymphangioleiomyomatosis: a clinical update.
@ast
Lymphangioleiomyomatosis: a clinical update.
@en
Lymphangioleiomyomatosis: a clinical update.
@nl
P356
P1433
P1476
Lymphangioleiomyomatosis: a clinical update
@en
P2093
Francis X McCormack
P304
P356
10.1378/CHEST.07-0898
P407
P577
2008-02-01T00:00:00Z